Molecular heterogeneity analysis of poly(amidoamine) dendrimer-based mono- and multifunctional nanodevices by capillary electrophoresis

被引:46
作者
Shi, XY [1 ]
Majoros, IJ [1 ]
Patri, AK [1 ]
Bi, XD [1 ]
Islam, MT [1 ]
Desai, A [1 ]
Ganser, TR [1 ]
Baker, JR [1 ]
机构
[1] Univ Michigan, Michigan Nanotechnol Inst Med & Biol Sci, Ann Arbor, MI 48109 USA
关键词
D O I
10.1039/b515624f
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
Poly( amidoamine) ( PAMAM) dendrimer-based nanodevices are of recent interest in targeted cancer therapy. Characterization of mono- and multifunctional PAMAM-based nanodevices remains a great challenge because of their molecular complexity. In this work, various mono- and multifunctional nanodevices based on PAMAM G5 ( generation 5) dendrimer were characterized by UV-Vis spectrometry, H-1 NMR, size exclusion chromatography ( SEC), and capillary electrophoresis (CE). CE was extensively utilized to measure the molecular heterogeneity of these PAMAM-based nanodevices. G5 - FA ( FA denotes folic acid) conjugates ( synthesized from amine-terminated G5. NH2 dendrimer, approach 1) with acetamide and amine termini exhibit bimodal or multi-modal distributions. In contrast, G5 - FA and bifunctional G5 - FA - MTX ( MTX denotes methotrexate) conjugates with hydroxyl termini display a single modal distribution. Multifunctional G5. Ac-n - FI - FA, G5. Ac-n - FA - OH - MTX, and G5. Ac-n - FI - FA - OH - MTX (Ac denotes acetamide; FI denotes fluorescein) nanodevices ( synthesized from partially acetylated G5 dendrimer, approach 2) exhibit a monodisperse distribution. It indicates that the molecular distribution of PAMAM conjugates largely depends on the homogeneity of starting materials, the synthetic approaches, and the final functionalization steps. Hydroxylation functionalization of dendrimers masks the dispersity of the final PAMAM nanodevices in both synthetic approaches. The applied CE analysis of mono- and multifunctional PAMAM-based nanodevices provides a powerful tool to evaluate the molecular heterogeneity of complex dendrimer conjugate nanodevices for targeted cancer therapeutics.
引用
收藏
页码:374 / 381
页数:8
相关论文
共 39 条
  • [1] Abu-Rmaileh R., 2003, DRUG DELIV SYST SCI, V3, P65
  • [2] [Anonymous], DENDRIMERS OTHER DEN
  • [3] The Synthesis and Testing of Anti-Cancer Therapeutic Nanodevices
    Baker, James R., Jr.
    Quintana, Antonio
    Piehler, Lars
    Banazak-Holl, Mark
    Tomalia, Donald
    Raczka, Ewa
    [J]. BIOMEDICAL MICRODEVICES, 2001, 3 (01) : 61 - 69
  • [4] Dendrimers as potential drug carriers; encapsulation of acidic hydrophobes within water soluble PAMAM derivatives
    Beezer, AE
    King, ASH
    Martin, IK
    Mitchell, JC
    Twyman, LJ
    Wain, CF
    [J]. TETRAHEDRON, 2003, 59 (22) : 3873 - 3880
  • [5] Slab-gel and capillary electrophoretic characterization of polyamidoamine dendrimers
    Brothers, HM
    Piehler, LT
    Tomalia, DA
    [J]. JOURNAL OF CHROMATOGRAPHY A, 1998, 814 (1-2) : 233 - 246
  • [6] Dendritic chelating agents. 1. Cu(II) binding to ethylene diamine core poly(amidoamine) dendrimers in aqueous solutions
    Diallo, MS
    Christie, S
    Swaminathan, P
    Balogh, L
    Shi, XY
    Um, W
    Papelis, C
    Goddard, WA
    Johnson, JH
    [J]. LANGMUIR, 2004, 20 (07) : 2640 - 2651
  • [7] Folic-acid-mediated inhibition of human colon-cancer cell growth
    Duthie, SJ
    [J]. NUTRITION, 2001, 17 (09) : 736 - 737
  • [8] Application of capillary zone electrophoresis to the separation and characterization of poly(amidoamine) dendrimers with an ethylenediamine core
    Ebber, A
    Vaher, M
    Peterson, J
    Lopp, M
    [J]. JOURNAL OF CHROMATOGRAPHY A, 2002, 949 (1-2) : 351 - 358
  • [9] Poly(amidoamine) (PAMAM) dendrimers: from biomimicry to drug delivery and biomedical applications
    Esfand, R
    Tomalia, DA
    [J]. DRUG DISCOVERY TODAY, 2001, 6 (08) : 427 - 436
  • [10] Positional and compositional heterogeneity of partially modified poly(propyleneimine) dendrimers
    Froehling, PE
    Linssen, HAJ
    [J]. MACROMOLECULAR CHEMISTRY AND PHYSICS, 1998, 199 (08) : 1691 - 1695